Marcus Schindler

Chief Tech/Sci/R&D Officer presso NOVO NORDISK A/S

57 anni

Health Technology

Consumer Services

Profilo

Marcus Schindler è Chief Scientific Officer & Executive VP-Research di Novo Nordisk A. Ha ricevuto un dottorato dall'Università di Cambridge.

Società	Posizione	Inizio
NOVO NORDISK A/S	Chief Tech/Sci/R&D Officer	01/03/2021

Società	Posizione	Fine
INNATE PHARMA	Director/Board Member	28/05/2021
The Oxford	Chief Tech/Sci/R&D Officer	29/02/2008
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK	Chief Tech/Sci/R&D Officer	-
AstraZeneca A/S /Denmark/ AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark.	Corporate Officer/Principal	-

University of Cambridge	Doctorate Degree
University of Gottingen	Graduate Degree

Attive

Inattive

Società quotate in Borsa

Aziende private

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società quotate in Borsa	2
NOVO NORDISK A/S	Health Technology
INNATE PHARMA	Health Technology

Aziende private	3
The Oxford	Consumer Services
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK	Health Technology
AstraZeneca A/S /Denmark/ AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark.	Health Technology